0001047469-04-005148 Sample Contracts

NEORX CORPORATION CHANGE OF CONTROL AGREEMENT (CEO)
Change of Control Agreement • February 23rd, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances

THIS CHANGE OF CONTROL AGREEMENT (CEO) (this "Agreement"), dated as of February 19, 2004, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 13, the "Company"), and JACK L. BOWMAN (the "Executive").

Sample 1Sample 2Sample 3See All (28)
AutoNDA by SimpleDocs
NEORX CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENT
Key Executive Severance Agreement • February 23rd, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances

This Key Executive Severance Agreement (VP) (this "Agreement"), dated as of February 28, 2003, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 10, the "Company"), and Linda Findlay (the "Executive").

Sample 1Sample 2Sample 3
NEORX CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENT
Key Executive Severance Agreement • February 23rd, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances • Washington

This Key Executive Severance Agreement (VP) (this "Agreement"), dated as of May 13, 2003, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 10, the "Company"), and KAREN AUDITORE-HARGREAVES (the "Executive").

Sample 1
NEORX CORPORATION CHANGE OF CONTROL AGREEMENT
Change of Control Agreement • February 23rd, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances • Washington

This Change of Control Agreement (VP) (this "Agreement"), dated as of May 13, 2003, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 13, the "Company"), and KAREN AUDITORE-HARGREAVES (the "Executive").

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!